ATE530913T1 - Verwendung eines synthetischen peptids aus dem zebra-protein für die in-vitro diagnose von eppstein-barr-virus (ebv)-reaktivierung - Google Patents
Verwendung eines synthetischen peptids aus dem zebra-protein für die in-vitro diagnose von eppstein-barr-virus (ebv)-reaktivierungInfo
- Publication number
- ATE530913T1 ATE530913T1 AT09719883T AT09719883T ATE530913T1 AT E530913 T1 ATE530913 T1 AT E530913T1 AT 09719883 T AT09719883 T AT 09719883T AT 09719883 T AT09719883 T AT 09719883T AT E530913 T1 ATE530913 T1 AT E530913T1
- Authority
- AT
- Austria
- Prior art keywords
- ebv
- reactivation
- eppstein
- synthetic peptide
- barr virus
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 241000283070 Equus zebra Species 0.000 title abstract 2
- 238000000338 in vitro Methods 0.000 title abstract 2
- 102000004169 proteins and genes Human genes 0.000 title abstract 2
- 108090000623 proteins and genes Proteins 0.000 title abstract 2
- 241000700605 Viruses Species 0.000 title 1
- 238000003745 diagnosis Methods 0.000 title 1
- 230000007420 reactivation Effects 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 206010015108 Epstein-Barr virus infection Diseases 0.000 abstract 1
- 102000001708 Protein Isoforms Human genes 0.000 abstract 1
- 108010029485 Protein Isoforms Proteins 0.000 abstract 1
- 239000012472 biological sample Substances 0.000 abstract 1
- 230000007170 pathology Effects 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
- 230000007419 viral reactivation Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56994—Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/01—DNA viruses
- G01N2333/03—Herpetoviridae, e.g. pseudorabies virus
- G01N2333/05—Epstein-Barr virus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08290224A EP2101177A1 (en) | 2008-03-10 | 2008-03-10 | Use of synthetic peptide derived from zebra protein for the in vitro diagnosis of the epstein-barr virus (EBV) reactivation |
| PCT/EP2009/052798 WO2009112497A1 (en) | 2008-03-10 | 2009-03-10 | Use of synthetic peptide derived from zebra protein for the in vitro diagnosis of the epstein-barr virus (ebv) reactivation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE530913T1 true ATE530913T1 (de) | 2011-11-15 |
Family
ID=39595705
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT09719883T ATE530913T1 (de) | 2008-03-10 | 2009-03-10 | Verwendung eines synthetischen peptids aus dem zebra-protein für die in-vitro diagnose von eppstein-barr-virus (ebv)-reaktivierung |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20110076671A1 (enExample) |
| EP (2) | EP2101177A1 (enExample) |
| JP (1) | JP5592277B2 (enExample) |
| CN (1) | CN102016586B (enExample) |
| AT (1) | ATE530913T1 (enExample) |
| CA (1) | CA2718245C (enExample) |
| ES (1) | ES2375095T3 (enExample) |
| MY (1) | MY156432A (enExample) |
| WO (1) | WO2009112497A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2983482B1 (fr) | 2011-12-05 | 2017-10-20 | Univ Joseph Fourier | Utilisation d'au moins un biomarqueur pour le pronostic ou le diagnostic in vitro d'episodes lymphoproliferatifs associes au virus d'epstein-barr (ebv) |
| WO2014025254A1 (en) | 2012-08-10 | 2014-02-13 | Stichting Vu-Vumc | Ebv markers and systemic lupus erythematosus |
| CN109679975B (zh) * | 2019-01-23 | 2020-12-08 | 济宁医学院 | 一种改造bzlf1和改造lmp1的融合基因及其应用 |
| CN113061165B (zh) * | 2020-01-02 | 2026-04-21 | 厦门大学 | EB病毒BNLF2b基因编码多肽及其检测用途 |
| CN111826412A (zh) * | 2020-06-02 | 2020-10-27 | 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） | 一种高通量检测eb病毒感染效率/抗体阻断eb病毒感染效率的方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE428724T1 (de) * | 1992-09-15 | 2009-05-15 | Ortho Diagnostic Systems Inc | Immunreaktive peptide des epstein-barrvirus |
| FR2728904B1 (fr) * | 1995-01-04 | 1997-03-14 | Pasteur Institut | Reactif peptidique permettant de detecter une infection primaire a virus d'epstein-barr par recherche des anticorps correspondants, et procede d'utilisation de ce reactif |
| PT747481E (pt) * | 1995-06-06 | 2002-05-31 | Organon Teknika Bv | Peptidos do virus de epstein-barr e anticorpos contra estes peptidos |
| JPH11511853A (ja) * | 1996-03-29 | 1999-10-12 | オルソ ダイアグノスティック システムズ インク | エプスタイン・バーウイルス関連疾患の診断法 |
| FR2791142B1 (fr) * | 1999-03-17 | 2001-06-22 | Univ Grenoble 1 | Utilisation de la brefeldine a pour augmenter l'effet de presentation d'antigenes exogenes par les cpa |
| CA2630218A1 (en) * | 2005-11-18 | 2007-08-30 | The Ohio State University Research Foundation | Viral gene products and methods for vaccination to prevent viral associated diseases |
-
2008
- 2008-03-10 EP EP08290224A patent/EP2101177A1/en not_active Withdrawn
-
2009
- 2009-03-10 AT AT09719883T patent/ATE530913T1/de not_active IP Right Cessation
- 2009-03-10 US US12/921,804 patent/US20110076671A1/en not_active Abandoned
- 2009-03-10 CN CN200980115338.9A patent/CN102016586B/zh not_active Expired - Fee Related
- 2009-03-10 WO PCT/EP2009/052798 patent/WO2009112497A1/en not_active Ceased
- 2009-03-10 CA CA2718245A patent/CA2718245C/en not_active Expired - Fee Related
- 2009-03-10 MY MYPI2010004281A patent/MY156432A/en unknown
- 2009-03-10 EP EP09719883A patent/EP2269069B1/en not_active Not-in-force
- 2009-03-10 ES ES09719883T patent/ES2375095T3/es active Active
- 2009-03-10 JP JP2010550179A patent/JP5592277B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN102016586A (zh) | 2011-04-13 |
| CA2718245C (en) | 2017-04-18 |
| CN102016586B (zh) | 2015-01-21 |
| WO2009112497A1 (en) | 2009-09-17 |
| ES2375095T3 (es) | 2012-02-24 |
| MY156432A (en) | 2016-02-26 |
| CA2718245A1 (en) | 2009-09-17 |
| US20110076671A1 (en) | 2011-03-31 |
| EP2101177A1 (en) | 2009-09-16 |
| EP2269069A1 (en) | 2011-01-05 |
| JP5592277B2 (ja) | 2014-09-17 |
| EP2269069B1 (en) | 2011-10-26 |
| JP2011513759A (ja) | 2011-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Fraioli et al. | Surface guidance of stem cell behavior: chemically tailored co-presentation of integrin-binding peptides stimulates osteogenic differentiation in vitro and bone formation in vivo | |
| MX2012002139A (es) | Anticuerpo anti-cmet y su uso para la deteccion y diagnostico del cancer. | |
| WO2003070894A3 (en) | A non-invasive diagnostic test utilizing histone modification markers | |
| WO2006127861A3 (en) | Diagnosis of diseases and conditions by analysis of histopathologically processed biological samples using liquid tissue preparations | |
| MX2009009226A (es) | Anticuerpos recombinantes para el tratamiento de infecciones con el virus respiratorio sincitial. | |
| ES2572372T3 (es) | Método de diagnóstico de enfermedades neurodegenerativas basado en la medición de los niveles o de la actividad de SIRT1 | |
| FI3256579T3 (fi) | Kysteiiniproteaasi | |
| CY1119412T1 (el) | Μεθοδοι για την αξιολογηση μιας ανοσοαποκρισης σε εναν θεραπευτικο παραγοντα | |
| BRPI0607315A2 (pt) | polinucleotìdeo isolado, vetor de expressão, composição, método de produzir uma molécula de ligação de antìgeno, molécula de ligação de antìgeno e o uso da mesma-, método para detectar in vivo ou in vitro a presença de egfr em uma amostra, célula hospedeira engendrada, composição farmacêutica e o uso da mesma | |
| UY31114A1 (es) | Anticuerpos humanizados contra el globulómero ab(20-42) y sus usos | |
| EP2365335A3 (en) | Diagnostic method | |
| ATE525648T1 (de) | Testelement mit nanofasern | |
| ATE553778T1 (de) | Für humanes hepcidin spezifische antikörper | |
| MX2009005788A (es) | Peptidos truncados de hormona paratiroidea con una conformacion ciclica. | |
| ATE410178T1 (de) | Oligopeptide zur verringerung erhöhter blutharnstoffkonzentration | |
| MY156432A (en) | Use of synthetic peptide derived from zebra protein for the in vitro diagnosis of the epstein-barr virus (ebv) reactivation | |
| Natalello et al. | A major role for side-chain polyglutamine hydrogen bonding in irreversible ataxin-3 aggregation | |
| Schneider et al. | Decorin—an antagonist of TGF-β in astrocytes of the optic nerve | |
| EP1783204A3 (en) | Biological sample handling and imaging | |
| Bellegarda et al. | The Reissner fiber under tension in vivo shows dynamic interaction with ciliated cells contacting the cerebrospinal fluid | |
| FI20040255A7 (fi) | Menetelmä pre-eklampsian riskin havaitsemiseksi | |
| BRPI0811429A2 (pt) | método para a detecção da atividade in vivo de neurotripsina, uso do método e uso do fragmento c-terminal de 22-kda de agrina como biomarcador no diagnóstico e monitoramento de distúrbios relacionados à neurotripsina | |
| DE602006013143D1 (de) | Verfahren zum nachweis aggregatbildender zirkulierender proteinformen und mittel zum einfangen gebildeter aggregate | |
| Konorov et al. | Raman microspectroscopy of live cells under autophagy-inducing conditions | |
| TN2010000421A1 (en) | Use of synthetic peptide derived from zebra protein for the in vitro diagnosis of the epstein-barr virus (ebv) reactivation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |